ReviewAdvanced healthcare materials2026
Rational Design of Controlled Aroma Delivery Systems for Bioactive Applications.
Review in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Links between aroma perception and regulatory function have been well established. In particular, fragrant molecules, with their distinctive aromas, possess the remarkable capacity to evoke sensory perceptions and produce a perceptual response. The physiological responses elicited by fragrances are fundamentally dependent on the controlled release of these aromatic molecules, underscoring the critical importance of release mechanisms. Here we provide the holistic analysis of the current landscape of aroma delivery systems (ADS) to reveal trends in controlled aroma release platforms development. We highlight rationales that fragrance nano- or microcapsules, fragrances releasing systems based on porous materials, profragrances design strategy capable of responding to environmental stimulus. In particular, we underline the advanced applications of these strategies in odor enhancement, bacterial inhibition, central nervous system regulation, and lung protection. We discuss how ADS can enhance olfactory appeal, modulate anxiety- and memory-related responses, inhibit pathogenic bacteria through synergistic effects such as metal-ion release, and contribute to lung protection by reducing cigarette smoke-induced oxidative stress. On the basis of this analysis, we discuss strengths and limitations of current aroma deliver approaches and suggest areas for future development. We hope in doing so, the reader will appreciate the current challenges and available opportunities in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.